← BRBI BR Partners S.A.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities | ||||||||||||
| Financial assets at fair value through profit or loss | — | — | — | — | — | — | — | ($1.4b) | ($1.6b) | ($2.4b) | — | |
| Financial liabilities at fair value through profit or loss | — | — | — | — | — | — | — | — | — | $33.2m | — | |
| Profit or Loss | — | — | — | ($172k) | ($246k) | ($326k) | — | — | ($298k) | ($2.9m) | — | |
| Net loss | $33k | ($509k) | ($202k) | $68.6m | $60.8m | ($326k) | ($287k) | ($8.5m) | ($298k) | $106.6m | — | |
| Depreciation and amortization | $129.6m | $127.9m | $125.2m | $120.9m | $116.8m | $104.6m | $58.8m | $6.7m | $7.5m | $10.8m | $11.0m | |
| Depreciation Expense | $76k | $57k | $52k | — | — | — | — | — | — | — | $11.0m | |
| Deferred taxes | — | — | — | — | — | — | — | ($6.1m) | $7.5m | $31.2m | — | |
| Stock-based compensation | $39k | $4k | $300k | — | — | — | — | — | — | $528k | — | |
| Stock-based compensation – related party | — | — | — | $23k | — | — | — | $8.1m | — | — | — | |
| Impairment losses | — | — | — | — | — | — | — | $1.5m | $14.4m | $13.1m | — | |
| Goodwill Impairment | — | — | — | — | — | — | — | — | — | $5k | $15.9m | |
| Equity in losses and impairment charges for investments in unconsolidated affiliates | — | — | — | — | — | — | $2.6m | $6.3m | $18.1m | $29.9m | — | |
| Receivables | — | — | — | — | — | — | — | — | $44k | — | $113.1m | |
| Accounts receivable | $143k | ($23k) | ($108k) | ($281k) | $605k | $63k | ($7.1m) | $15.1m | $1.3m | ($4.1m) | $113.1m | |
| Accounts receivable-other | ($45k) | ($18k) | ($229k) | $183k | $185k | — | — | — | — | — | $113.1m | |
| Provision for inventory reserve | ($43k) | $54k | ($30k) | — | — | — | — | — | — | — | — | |
| (Increase) decrease in inventories | $90k | $13k | ($78k) | $14.4m | ($1.6m) | ($14.8m) | ($4.8m) | $5.1m | $6.6m | ($14.1m) | — | |
| Accounts payable and accrued expenses | — | — | — | ($7k) | ($764k) | $1k | $8k | ($41k) | $4k | $1.0m | $977k | |
| Increase (decrease) in accounts payable | ($19k) | $174k | $94k | — | — | — | — | — | — | — | $977k | |
| Accounts payable | ($1.9m) | $7.1m | $809k | ($7.0m) | $1.5m | $6.8m | ($4.3m) | ($206k) | $1.1m | $939k | $977k | |
| Deferred revenue | — | — | ($1.5m) | $2.4m | $6.6m | ($69k) | $15.9m | ($281k) | $8k | ($4.8m) | — | |
| Change in Deferred Revenue | ($30k) | — | — | ($13k) | — | — | — | — | — | — | — | |
| Change in Accrued Liabilities | ($155k) | $73k | $13k | — | — | — | — | — | — | — | — | |
| Accrued employment and benefit costs | ($12.7m) | $10.9m | $5.0m | $2.3m | $526k | $5.6m | $2.3m | $1.5m | ($5.2m) | $6.3m | — | |
| Accrued insurance | $2.6m | $8.9m | $2.0m | ($3.3m) | $5.7m | ($6.8m) | ($2.1m) | ($2.9m) | ($3.1m) | ($1.4m) | — | |
| Other assets | — | — | — | — | — | — | — | ($5.2m) | $42k | $386k | — | |
| Prepaid expenses and other current assets | — | — | — | $1k | ($5k) | $8k | ($4k) | $4k | ($4k) | ($9k) | — | |
| Decrease in other assets | — | — | — | — | $47k | — | — | — | — | — | — | |
| Other current and noncurrent assets | $2.0m | ($9.6m) | ($5.4m) | $8.2m | ($9.8m) | ($40.0m) | ($5.4m) | $6.1m | ($2.8m) | $18.6m | — | |
| Other current and noncurrent liabilities | $12.5m | $1.6m | $9.3m | $1.6m | $16.9m | $33.1m | $15.8m | $2.4m | ($4.9m) | ($32.5m) | — | |
| Cash flows from investing activities | ||||||||||||
| Acquisition of property, plant and equipment for use | $6.0m | $5.2m | $5.9m | $5.8m | $4.9m | $4.5m | $5.2m | ($2.2m) | ($2.8m) | ($572k) | — | |
| Purchase of equipment on capital lease | ($38.4m) | ($28.2m) | ($32.9m) | ($35.0m) | ($32.5m) | ($29.9m) | ($44.4m) | ($44.9m) | ($59.4m) | ($72.0m) | — | |
| Investments in and acquisitions of businesses | ($42.9m) | $0 | ($14.9m) | ($19.3m) | ($25.6m) | ($8.7m) | ($56.1m) | ($130.1m) | ($25.2m) | ($59.5m) | — | |
| Net Cash from Investing Activities | — | — | ($10k) | — | — | — | — | — | — | $150k | — | |
| Net cash flows (used in) provided by investing activities | ($53.9m) | ($23.0m) | ($10k) | $88k | ($16k) | ($34.1m) | ($94.4m) | ($170.6m) | ($81.6m) | ($128.3m) | — | |
| Cash flows from financing activities | ||||||||||||
| - Debt issued and others | — | — | — | — | — | — | — | $75.0m | $842.6m | $1.6b | — | |
| Forgiveness of debt - related party | — | — | — | — | — | — | — | — | — | $14k | — | |
| Proceeds from Debt Issuance | — | $150k | — | — | — | — | — | $40k | — | — | — | |
| Repayments of Debt | ($7k) | — | — | — | — | — | — | — | — | — | ($205.3m) | |
| Loss on debt extinguishment | $292k | $1.6m | $0 | $0 | $109k | $16.0m | $0 | $0 | $215k | $0 | — | |
| Proceeds from borrowings under revolving credit facility | $100.0m | $374.8m | $350.1m | $370.7m | $493.0m | $447.0m | $386.6m | $525.7m | $626.0m | $459.2m | — | |
| Repayments of borrowings under revolving credit facility | ($100.0m) | ($312.2m) | ($369.1m) | ($400.8m) | ($511.9m) | ($409.6m) | ($429.0m) | ($483.3m) | ($607.0m) | ($461.0m) | — | |
| Issuance costs associated with long-term borrowings | ($2.7m) | ($7.1m) | $0 | $0 | ($2.7m) | ($10.8m) | $0 | $0 | ($3.7m) | $0 | — | |
| Proceeds from long-term borrowings | $0 | $350.0m | $0 | $0 | $0 | $650.0m | $0 | $0 | — | — | — | |
| Repayments of long-term borrowings | $0 | ($360.9m) | $0 | $0 | $0 | ($786.3m) | $0 | $0 | — | — | — | |
| Repayment of long-term borrowings (includes premium and fees) | $0 | — | — | — | — | — | — | — | — | — | — | |
| Common Stock issued for services | — | — | — | — | — | — | — | — | — | $139k | — | |
| Common Stock issued for the acquisition of Bio-Convert | — | — | — | — | — | — | — | — | — | $39.0m | — | |
| Common Stock issued for the acquisition of Orocidin | — | — | — | — | — | — | — | — | — | $19.0m | — | |
| Dividends paid | — | — | — | — | — | — | — | ($139) | ($205) | ($195) | $31.8m | |
| Deemed dividend | — | — | — | — | — | — | — | — | $1.4m | — | — | |
| Cash generated by (used in) in financing activities | — | — | — | — | — | — | — | ($68.4m) |
$154.6m
+326.01%
|
($51.6m)
-133.40%
|
— | |
| Net Cash from Financing Activities | — | — | — | — | — | — | — | $115k |
$306k
+166.09%
|
$889k
+190.68%
|
— | |
| Net cash provided (used) by financing activities | ($57k) |
$150k
+363.16%
|
($5k)
-103.33%
|
($5k)
0.00%
|
$49k
+1080.00%
|
($5.1m)
-10481.63%
|
$400k
+107.86%
|
$129k
-67.78%
|
$305k
+136.82%
|
($66.7m)
-21967.15%
|
— | |
| Increase (decrease) in cash and cash equivalents | — | — | — | — | — | — | — | $156.4m | $241.9m | ($476.9m) | — | |
| Net (decrease) increase in cash, cash equivalents and restricted cash | — | — | $2.4m | ($2.7m) | $699k | $2.7m | ($1.7m) | $10.0m | $6.4m | ($8.7m) | — | |
| Net increase (decrease) in cash and cash equivalents | ($115.0m) | ($34.6m) | $2.4m | — | — | — | — | — | — | — | — | |
| Cash and cash equivalents at the beginning of the year | — | — | — | — | — | — | — | $287.2m | $575.2m | $137.8m | — | |
| Cash at beginning of period | — | $80k | $27k | — | — | — | — | $246k | $7k | $50k | — | |
| Cash at beginning of year | — | — | — | $120k | $172k | $5.5m | $128k | $246k | $14.1m | $20.5m | — | |
| Less: restricted cash | — | — | — | — | — | $0 | $0 | $10.6m | $17.3m | $11.4m | — | |
| Effect of changes in exchange rates on cash and cash equivalents | — | — | — | — | — | — | — | $53.3m | $46.1m | $39.4m | — | |
| Effect of Exchange Rate on Cash | — | — | — | — | — | — | — | $665 | ($4k) | $27k | $35.6m | |
| Additional Supplementary Disclosures | ||||||||||||
| Additional Supplementary Disclosures | ||||||||||||
| Profit | — | — | — | — | — | — | — | $155.1m | $193.7m | $175.1m | — | |
| Provision for contingencies | — | — | — | — | — | — | — | $143k | $162k | ($326k) | — | |
| Interest - subordinated financial bills | — | — | — | — | — | — | — | $165k | $25.5m | $94.8m | — | |
| Total | — | — | — | — | — | — | — | $104.2m | $202.5m | $285.3m | — | |
| Derivative financial instruments | — | — | — | — | — | — | — | $342.9m | ($943.2m) | $75.0m | — | |
| - Loans | — | — | — | — | — | — | — | $36.4m | ($161.2m) | $148.4m | — | |
| - Other financial assets at amortized cost | — | — | — | — | — | — | — | ($961.4m) | ($231.0m) | $290.7m | — | |
| Financial assets at fair value through other comprehensive income | — | — | — | — | — | — | — | ($409.4m) | ($1.2b) | ($930.2m) | — | |
| Amounts payable – suppliers | — | — | — | — | — | — | — | $1.4m | $11.3m | ($4.8m) | — | |
| - Repurchase agreements | — | — | — | — | — | — | — | $697.3m | $2.4b | $1.9b | — | |
| - Client deposits | — | — | — | — | — | — | — | $760.4m | $570.1m | ($989.5m) | — | |
| - Other financial liabilities | — | — | — | — | — | — | — | $939.6m | $195.3m | ($357.6m) | — | |
| Taxes payable | — | — | — | — | — | — | — | $59.5m | $14.4m | $32.6m | — | |
| Other amounts payable | — | — | — | — | — | — | — | $7.1m | ($568k) | ($35.0m) | — | |
| Income tax and social contribution paid | — | — | — | — | — | — | — | ($58.6m) | ($36.2m) | ($31.9m) | — | |
| Acquisition of intangible assets | — | — | — | — | — | — | — | ($5.8m) | — | — | — | |
| Cash (used in) investing activities | — | — | — | — | — | — | — | ($8.0m) | ($2.8m) | ($572k) | — | |
| Lease liabilities | — | — | — | — | — | — | — | ($2.4m) | ($6.4m) | ($8.2m) | — | |
| Issuance of subordinated financial bills | — | — | — | — | — | — | — | $72.6m | $372.9m | $194.4m | — | |
| Payment of coupons financial bills | — | — | — | — | — | — | — | — | ($7.2m) | ($42.6m) | — | |
| Interest received | — | — | — | — | — | — | — | $826.4m | $1.2b | $1.4b | — | |
| Interest paid | $74.3m | $76.6m | — | — | — | — | — | ($657.0m) | ($1.4b) | ($1.4b) | ($64.4m) | |
| Non-Operating Income (Expense) | — | — | — | — | — | — | — | — | — | $173k | — | |
| Change in fair value of investment | — | — | — | — | — | — | — | — | — | ($175k) | — | |
| Related party payable | — | — | — | — | — | — | ($5k) | — | ($12k) | — | — | |
| Cash paid for website costs | — | — | — | — | — | — | — | — | — | ($2k) | — | |
| Cash distribution to stockholder | ($215.5m) | ($216.6m) | ($147.2m) | ($147.9m) | ($130.2m) | ($5.1m) | ($81.7m) | ($82.4m) | ($775) | ($84.2m) | — | |
| Cash paid for stock issuance costs in business combinations | — | — | — | — | — | — | — | — | — | ($3k) | — | |
| Stock Repurchases (Issuances) | — | — | — | — | $189k | — | $400k | — | — | $193k | — | |
| Net change in cash | $5k | ($53k) | $93k | $52k | $5.4m | ($5.4m) | $118k | ($239k) | $46k | ($57k) | — | |
| Cancellation of liability-classified warrants – Related party | — | — | — | — | — | — | — | — | — | $167k | — | |
| Repayment of note payable | — | — | — | — | — | — | — | ($40k) | — | — | — | |
| Income Tax Expense | — | — | — | — | — | $15k | — | — | — | — | — | |
| Interest Expense | $339k | $349k | $373k | $382k | $393k | $64.9m | $59.2m | $67.5m | $73.6m | $73.9m | — | |
| Prepaid expenses | $1k | — | $1k | — | — | — | ($4k) | $4k | — | — | — | |
| Income from Discontinued Operations | — | — | — | $506k | $5.7m | — | — | — | — | — | — | |
| Customer advance | — | — | — | ($271k) | $45k | ($69k) | — | — | — | — | — | |
| Proceeds from Sale of PP&E | — | — | — | $88k | $2.1m | — | — | — | — | — | — | |
| Sale-leaseback financing obligation | — | — | — | — | ($2.2m) | — | — | — | — | — | — | |
| Repayment of related party notes payable | — | — | — | ($5k) | ($140k) | — | — | — | — | — | — | |
| Increase (decrease) in customer advance | ($35k) | ($35k) | $288k | — | — | — | — | — | — | — | — | |
| Repayment of promissory note | ($50k) | — | ($5k) | — | — | — | — | — | — | — | — | |
| Cash at end of period | $75k | $27k | $120k | — | — | — | — | — | — | — | — | |
| Repayment of capital lease obligation | ($7k) | — | — | — | — | — | — | — | — | — | — | |
| Compensation costs recognized under Restricted Unit Plans | — | — | $8.2m | $10.5m | $9.2m | $10.1m | $11.3m | $8.3m | $8.2m | $7.8m | — | |
| Pension settlement charge | $2.0m | $6.1m | $0 | $0 | $1.1m | $958k | $840k | $0 | $638k | $528k | — | |
| Other, net | $9.2m | $9.3m | $1.1m | $1.7m | $923k | $3.1m | $357k | $1.5m | $4.1m | $4.5m | — | |
| Contributions to defined benefit pension plan | ($715k) | ($11.5m) | ($4.8m) | ($5.3m) | ($3.8m) | ($6.3m) | ($3.3m) | ($4.0m) | ($4.0m) | ($4.0m) | — | |
| Proceeds from sale of business | $21.5m | $0 | $2.8m | $0 | $0 | $0 | $850k | $0 | $0 | — | — | |
| Proceeds from the issuance of Common Units under an at-the-market equity program, net of commissions and offering costs | — | — | — | — | — | — | — | $0 | $0 | $23.5m | — | |
| Cash and cash equivalents, end of period | $152.3m | $37.3m | $2.8m | $5.2m | $2.4m | $5.8m | $4.1m | $3.5m | $3.2m | $405k | — | |
| Loss on sale of business | ($9.8m) | $0 | $4.8m | $0 | $0 | — | — | — | — | — | — | |
| Customer deposits and advances | $1.2m | ($9.1m) | ($1.5m) | — | — | — | — | — | — | — | — |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.